• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-TSHR; THYROID AUTOANTIBODY TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-TSHR; THYROID AUTOANTIBODY TEST Back to Search Results
Catalog Number 08496633190
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/27/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Medwatch field e1.Facility name - (b)(6).The patient's sample was provided for investigation.The investigation is ongoing.
 
Event or Problem Description
The initial reporter stated they received discrepant results for one patient sample tested with elecsys ft3 iii, elecsys ft4 iv, and elecsys anti-tshr on a cobas e 801 analytical unit.The sample results measured on the e 801 analyzer did not compare to results measured using the abbott methods.This medwatch will apply to the anti-tshr assay.Please refer to the medwatch with a1.Patient identifier (b)(6) for information related to the ft3 assay and refer to the medwatch with a1.Patient identifier (b)(6) for information related to the ft4 assay.The results measured on the e 801 analyzer are as follows: ft3 = 12.2 pmol/l (reference range = 3.1 - 6.8 pmol/l),, ft4 = 59.9 pmol/l (reference range = 12 - 22 pmol/l), anti-tshr tested on (b)(6) 2025 = 14.00 iu/l (positive).The results measured using the abbott method are as follows: ft3 = 4.08 pmol/l (reference range = 3.45 - 5.5 pmol/l), ft4 = 14.08 pmol/l (reference range = 11.0 - 17.7 pmol/l), anti-tshr tested on (b)(6) 2025 = <0.7 iu/l (negative).
 
Additional Manufacturer Narrative
Investigations of the patient sample determined it contains an interfering factor against the ruthenium component of the anti-tshr assay.Per product labeling, "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-TSHR
Common Device Name
THYROID AUTOANTIBODY TEST
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key22088253
Report Number1823260-2025-01620
Device Sequence Number6907160
Product Code JZO
UDI-Device Identifier07613336160329
UDI-Public07613336160329
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K193313
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/27/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2025
Device Catalogue Number08496633190
Device Lot Number80193802
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/06/2025
Supplement Date Received by Manufacturer06/25/2025
Initial Report FDA Received Date05/27/2025
Supplement Report FDA Received Date06/27/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-